Effector T cells, which are abundant but are short-lived after reinfusion into the body, are generally used for T-cell therapy, and antitumor immunity is typically not maintained over the long term. Genetic modification by early differentiated T cells and reinfusion has been shown to enhance antitumor immunity in vivo. This study overexpressed the characteristic transcription factors of differentiated early T cells by transfecting effector T cells with transcription factor recombinant lentivirus (S6 group: BCL6, EOMES, FOXP1, LEF1, TCF7, KLF7; S1 group: BCL6, EOMES, FOXP1, KLF7; S3 group: BCL6, EOMES, FOXP1, LEF1) to induce a sufficient number of effector T cells to dedifferentiate and optimize the transcription factor system. The results revealed that overexpression of early characteristic transcription factors in effector T cells upregulated the expression of early T cell differentiation markers (CCR7 and CD62L), with the S1 group having the highest expression level, while the rising trend of late differentiation marker (CD45RO) expression was suppressed. Moreover, the expression of early differentiation-related genes (ACTN1, CERS6, BCL2) was significantly increased, while the expression of late differentiation-related genes (KLRG-1) and effector function-related genes (GNLY, GZMB, PRF1) was significantly decreased; this difference in expression was more significant in the S1 group than in the other two experimental groups. The antiapoptotic ability of each experimental group was significantly enhanced, while the secretion ability of TNF-α and IFN-γ was weakened, with the effector cytokine secretion ability of the S1 group being the weakest. Transcriptomic analysis showed that the gene expression profile of each experimental group was significantly different from that of the control group, with differences in the gene expression pattern and number of differentially expressed genes in the S1 group compared with the other two experimental groups. The differentially expressed gene enrichment pathways were basically related to the cell cycle, cell division, and immune function. In conclusion, overexpression of early characteristic transcription factors in effector T cells induces their dedifferentiation, and induction of dedifferentiation by the S1 group may be more effective.
文章引用产品列表
-
- CS0001
- 刺激阻断剂
Phorbol 12-Myristate 13-Acetate(PMA,佛波酯)
- ¥170.00 – ¥800.00
-
- CS0002
- 刺激阻断剂
Ionomycin Calcium(离子霉素)
- ¥460.00 – ¥4,460.00
-
- CS1002
- 刺激阻断剂
BFA/Monensin Mixture(250X) 布雷非德菌素A/莫能霉素混合物
- ¥460.00 – ¥2,060.00
-
- AT105
- 凋亡试剂盒
Annexin V-APC/7-AAD Apoptosis Kit(细胞凋亡试剂盒 - 贴壁细胞专用)
- ¥1,010.00 – ¥2,090.00
-
- AP105
- 凋亡试剂盒
Annexin V-APC/7-AAD Apoptosis Kit 细胞凋亡试剂盒
- ¥780.00 – ¥1,860.00
-
- EK182HS
- 高敏试剂盒
Human TNF-α High Sensitivity ELISA Kit检测试剂盒(酶联免疫吸附法)
- ¥2,000.00 – ¥3,400.00
-
- EK182
- ELISA试剂盒
Human TNF-a ELISA Kit检测试剂盒(酶联免疫吸附法)
- ¥1,600.00 – ¥10,800.00